We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Novartis Says FDA Erred in Approving Generic Famvir
Novartis Says FDA Erred in Approving Generic Famvir
October 1, 2010
Novartis has filed a lawsuit against the FDA accusing the agency of improperly approving Watson’s ANDA to market a generic version of the herpes drug Famvir.